GPCRs in Cardiovascular Pathologies

Drug Discovery Today: Disease Models - United Kingdom
doi 10.1016/j.ddmod.2012.07.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Asymmetric Dimethylarginine, the Promoter Factor of Cardiovascular Pathologies

Romanian Journal of Medical Practice
2019English

GPCRs' Grand Plans

Science-Business eXchange
2014English

Adhesion-GPCRs in Tumorigenesis

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
2010English

Hypertension Induction and Avoidance in the Patients With Neurosurgical Pathologies and Concomitant Cardiovascular Disorders

Archives in Neurology & Neuroscience
2019English

GPCRs – Pivotal Players in Metabolism

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2016English

Advancements in Therapeutically Targeting Orphan GPCRs

Frontiers in Pharmacology
Pharmacology
2015English

GPCRs and G Protein Activation

2012English

GPCRs as Potential Therapeutic Targets in Preeclampsia

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2012English

Ocular Pathologies Emerging in Pregnancy.

The Professional Medical Journal
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy